Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
QL Block vs Epidural in Radical Cystectomy
NCT04133051Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- Nov 2018
- Primary completion
- Sep 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of bupivacaine hydrochloride 0.75% injection in postoperative pain (2 arms), sponsored by National Cancer Institute. Primary endpoint: Visual Analogue Scale at 48 hours. Started Nov 2018; status: completed.
02
Drugs
bupivacaine hydrochloride 0.75% injection
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT04133051.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04133051.